Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:clinicalTrialPhase |
NCT00003906
|
| gptkbp:compared |
gptkb:tamoxifen
raloxifene |
| gptkbp:endDate |
2006
|
| gptkbp:enrolledParticipants |
postmenopausal women at increased risk for breast cancer
|
| gptkbp:fullName |
National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene
|
| https://www.w3.org/2000/01/rdf-schema#label |
NSABP STAR trial
|
| gptkbp:location |
gptkb:Canada
gptkb:United_States |
| gptkbp:principalInvestigator |
Norman Wolmark
|
| gptkbp:publicationYear |
2006
|
| gptkbp:publishedIn |
gptkb:New_England_Journal_of_Medicine
|
| gptkbp:result |
tamoxifen and raloxifene were similarly effective in reducing risk of invasive breast cancer
raloxifene had fewer side effects than tamoxifen |
| gptkbp:sponsor |
gptkb:National_Cancer_Institute
|
| gptkbp:startYear |
1999
|
| gptkbp:studiedBy |
breast cancer prevention
|
| gptkbp:bfsParent |
gptkb:Victor_G_Vogel_III
|
| gptkbp:bfsLayer |
7
|